Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
partnerships
Biotech
BioLineRx forges joint cancer venture with Norwegian biotech
The Israeli drug developer will manage, fund and perform all development activities for GLIX1, a small-molecule glioblastoma candidate.
Darren Incorvaia
Sep 29, 2025 11:22am
Philips, Masimo re-up patient monitor partnership with AI focus
Sep 12, 2025 12:00pm
Servier hands Ideaya $210M upfront for ex-US rights to PKC asset
Sep 2, 2025 3:02pm
Big Pharma-backed program seeks future beyond animal testing
Aug 1, 2025 5:00pm
GSK plans 'very limited' job cuts for global R&D team
Jul 15, 2025 4:15pm
CSL consolidates R&D team in shift toward external partners
Jul 7, 2025 12:44pm
